healthprotocol.wiki

eldisouky-hegazy-abd-elghany_2025_rct_l-carnitine-as-a-novel-approach-for-pain-and-inflammation-relief-in-rheumatoid-arthritis

18 findings

Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
biomarker-c-reactive-protein-high-sensitivity-serum-mg-per-liter-measured
n
23
effect
-40
attribution
70
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
biomarker-c-reactive-protein-high-sensitivity-serum-mg-per-liter-measured
n
23
effect
50
attribution
75
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
biomarker-stat3-serum-concentration-u-per-ml-measured
n
23
effect
-40
attribution
70
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
biomarker-stat3-serum-concentration-u-per-ml-measured
n
23
effect
0
attribution
65
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
biomarker-tgf-beta-1-serum-concentration-ng-per-liter-measured
n
23
effect
40
attribution
70
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
biomarker-tgf-beta-1-serum-concentration-ng-per-liter-measured
n
23
effect
0
attribution
65
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-intensity-vas-self-reported
n
23
effect
0
attribution
60
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-intensity-vas-self-reported
n
23
effect
50
attribution
75
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-musculoskeletal-das28-crp-score-measured
n
23
effect
-40
attribution
70
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-musculoskeletal-das28-crp-score-measured
n
23
effect
50
attribution
75
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-musculoskeletal-haq-modified-score-self-reported
n
23
effect
0
attribution
60
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-musculoskeletal-haq-modified-score-self-reported
n
23
effect
50
attribution
75
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-musculoskeletal-morning-stiffness-duration-minutes-self-reported
n
23
effect
0
attribution
60
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-musculoskeletal-morning-stiffness-duration-minutes-self-reported
n
23
effect
50
attribution
75
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-musculoskeletal-swollen-joint-count-measured
n
23
effect
0
attribution
60
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-musculoskeletal-swollen-joint-count-measured
n
23
effect
0
attribution
65
Protocol
medication-dmards-methotrexate-leflunomide-hydroxychloroquine-twelve-weeks
Outcome
pain-musculoskeletal-tender-joint-count-measured
n
23
effect
0
attribution
60
Protocol
supplement-l-carnitine-high-dose-twice-daily-adjunct-dmards-quarterly
Outcome
pain-musculoskeletal-tender-joint-count-measured
n
23
effect
50
attribution
75